Sales & Marketing News | pharmaphorum

News

Healthware Group appoints Eugene Borukhovich as senior advis...

Digital Health veteran Eugene Borukhovich has joined Healthware Group as senior advisor to its Media and Community business unit, which aims to foster dialogue and connections among the dig

News

Actemra shortage spills over to include Sanofi's rival Kevza...

Roche's Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to shortages.

News

Close-up image of a firm handshake between two colleagues

Supernus bulks up its Parkinson's portfolio with Adamas take...

Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson's disease therapies to its stabl

News

Oxford Nanopore makes stellar debut on UK stock market

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards th

News

Merck confirms $11.5bn Acceleron takeover deal

After days of speculation, Merck & Co confirmed today that it has agreed to acquire Acceleron Pharma $1.5 billion, setting up what could be one of the largest biopharma acquisitions of

News

Rumour mill says Acceleron is speeding towards $11bn sale

US biopharma company Acceleron is the next company heading for a takeover by a big pharma group – according to a Bloomberg report citing people close to the matter.

Healthware Group appoints Eugene Borukhovich as senior advis...

Actemra shortage spills over to include Sanofi's rival Kevza...

Supernus bulks up its Parkinson's portfolio with Adamas take...

Oxford Nanopore makes stellar debut on UK stock market

Merck confirms $11.5bn Acceleron takeover deal

Rumour mill says Acceleron is speeding towards $11bn sale

Bayer hits "turning point" in recovery plan, says CEO

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks